Lawrence S Lamb
Overview
Explore the profile of Lawrence S Lamb including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
267
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jones A, Tuy K, Hawkins C, Quinn C, Saad J, Gary S, et al.
Cancers (Basel)
. 2024 Aug;
16(16).
PMID: 39199623
Glioblastoma (GBM) is an immunologically cold tumor, but several immunotherapy-based strategies show promise, including the administration of ex vivo expanded and activated cytotoxic gamma delta T cells. Cytotoxicity is partially...
2.
Jones A, Rocco A, Lamb L, Friedman G, Hjelmeland A
Cancers (Basel)
. 2022 May;
14(9).
PMID: 35565467
Under cellular distress, multiple facets of normal homeostatic signaling are altered or disrupted. In the context of the immune landscape, external and internal stressors normally promote the expression of natural...
3.
Lamb L, Pereboeva L, Youngblood S, Gillespie G, Nabors L, Markert J, et al.
Sci Rep
. 2021 Oct;
11(1):21133.
PMID: 34702850
Chemotherapeutic drugs such as the alkylating agent Temozolomide (TMZ), in addition to reducing tumor mass, can also sensitize tumors to immune recognition by transient upregulation of multiple stress induced NKG2D...
4.
Saad A, Taneja A, Di Stasi A, Sarmad R, Kukkamalla R, Costa L, et al.
Bone Marrow Transplant
. 2018 May;
53(10):1345-1348.
PMID: 29728698
No abstract available.
5.
Lamb L, Pillai S, Langford S, Bowersock J, Di Stasi A, Saad A
Bone Marrow Transplant
. 2018 Mar;
53(6):766-769.
PMID: 29515253
No abstract available.
6.
Minagawa K, Jamil M, Al-Obaidi M, Pereboeva L, Salzman D, Erba H, et al.
PLoS One
. 2017 Feb;
12(2):e0172640.
PMID: 28199393
[This corrects the article DOI: 10.1371/journal.pone.0166891.].
7.
Minagawa K, Jamil M, Al-Obaidi M, Pereboeva L, Salzman D, Erba H, et al.
PLoS One
. 2016 Dec;
11(12):e0166891.
PMID: 27907031
Background: Approximately fifty percent of patients with acute myeloid leukemia can be cured with current therapeutic strategies which include, standard dose chemotherapy for patients at standard risk of relapse as...
8.
Pereboeva L, Harkins L, Wong S, Lamb L
Cancer Immunol Immunother
. 2015 Feb;
64(5):551-62.
PMID: 25676710
The standard treatment of high-grade glioma presents a combination of radiotherapy, chemotherapy and surgery. Immunotherapy is proposed as a potential adjunct to standard cytotoxic regimens to target remaining microscopic disease...
9.
Jones B, Lamb L, Goldman F, Di Stasi A
Front Pharmacol
. 2014 Dec;
5:254.
PMID: 25505885
Adoptive T-cell therapy can involve donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation, the administration of tumor infiltrating lymphocyte expanded ex-vivo, or more recently the use of T cell...
10.
Knight A, Arnouk H, Britt W, Gillespie G, Cloud G, Harkins L, et al.
PLoS One
. 2013 Aug;
8(8):e68729.
PMID: 23950874
Vδ2(neg) γδ T cells, of which Vδ1+ γδ T cells are by far the largest subset, are important effectors against CMV infection. Malignant gliomas often contain CMV genetic material and...